Grapiprant Improved Dog Arthritis in 36-Dog Study

A 36-dog clinical study found that 60 days of grapiprant reduced owner-reported mobility problems and changed blood markers linked to inflammation, supporting its use for canine osteoarthritis pain management.

Journal: Frontiers in Veterinary Science
Sample Size: 36 client-owned dogs with mild to moderate naturally occurring osteoarthritis
Study Type: Prospective off–on–off clinical study
Published: 2026-06-15
Species:

Key Findings

  • Sixty days of grapiprant reduced owner-reported mobility scores.
  • Plasma metabolomics showed treatment-associated changes consistent with reduced inflammation.

A Common Pain Drug Made It Easier for Arthritic Dogs to Move

Grapiprant, a prescription pain medication for dogs with arthritis, helped improve mobility and reduced signs of inflammation in a new clinical study of 36 dogs. After 60 days on the drug, owners reported that their dogs moved more easily — and blood tests showed changes in the dogs’ bodies that lined up with less inflammation.

If your dog has been slowing down, struggling to get up, or limping, this research offers some good news. It adds to growing evidence that grapiprant is a safe and effective option for managing the daily pain of canine osteoarthritis (joint disease caused by cartilage breakdown).

Why Arthritis Pain in Dogs Is Such a Big Problem

Osteoarthritis — the wear-and-tear kind of joint disease — is one of the most common health problems in dogs. It is estimated to affect roughly 1 in 5 adult dogs, and even more in older dogs or large breeds. The condition causes the cushioning cartilage inside joints to slowly break down. Once that cushioning is gone, bone rubs on bone, causing pain, swelling, and stiffness.

Many dogs hide pain well. You might notice your dog hesitating before jumping in the car, sleeping more, or just seeming less enthusiastic on walks. These can all be signs of joint pain.

Until recently, most vets managed arthritis pain in dogs with NSAIDs (non-steroidal anti-inflammatory drugs — the same family as ibuprofen in people, but dog-specific versions). Grapiprant works differently. Instead of broadly dampening inflammation throughout the body, it specifically blocks one protein — called the EP4 receptor — that sends pain signals from inflamed joints to the brain. Think of it like cutting one specific wire in an alarm system, rather than shutting off all the power.

How the Study Was Set Up

This was a prospective off–on–off clinical study — which means the researchers watched what happened when the medication was given, then stopped, then given again. That design helps confirm whether changes in a dog’s condition are actually due to the drug, rather than just coincidence.

  • 36 dogs with mild to moderate naturally occurring osteoarthritis took part.
  • All were owned by real families (not laboratory dogs), making the findings more relevant to everyday pet owners.
  • Dogs received grapiprant for 60 days.
  • Owners filled out questionnaires rating their dog’s mobility at different points during the study.
  • Blood samples were collected and analyzed using a technique called plasma metabolomics — essentially, a detailed snapshot of hundreds of small molecules circulating in the blood that can reveal what is happening inside the body at a chemical level.

What the Study Found

Dogs Moved Better

After 60 days on grapiprant, owner-reported mobility scores improved. In plain terms: the people living with these dogs noticed a real difference. Their pets were moving more easily than before treatment.

This type of measure — called an owner-assessed outcome — is especially meaningful because it reflects real life. It is not just a number on a lab test. It is a dog actually getting up more easily, trotting to the door, or not whimpering when touched.

Blood Chemistry Changed Too

The blood metabolomics results showed that grapiprant caused measurable changes in the dogs’ blood chemistry. The patterns of change were consistent with reduced inflammation — the kind of chemical shifts you would expect to see when the body is less inflamed and in less pain.

This is an exciting second layer of evidence. It means the drug was not just making dogs seem better on the outside. Something was changing on the inside, too.

Researchers noted that these blood-based changes could eventually help vets identify which dogs are most likely to respond well to grapiprant — a step toward more personalized treatment.

What This Means for You and Your Dog

Talk to Your Vet About Grapiprant

If your dog has been diagnosed with osteoarthritis — or if you suspect joint pain — grapiprant is worth discussing with your veterinarian. It is already FDA-approved for managing pain and inflammation from osteoarthritis in dogs, and this study adds more real-world support for its effectiveness.

Grapiprant may be a good option especially for dogs that have had stomach upset or other side effects from older pain medications. Because it targets a very specific pain pathway (rather than broadly suppressing inflammation), it tends to be gentler on the digestive system for many dogs.

Watch for These Signs of Arthritis in Your Dog

  • Stiffness after resting, especially first thing in the morning
  • Reluctance to climb stairs, jump, or play as much as before
  • Limping or favoring one leg
  • Licking or chewing at a specific joint
  • Grumpiness or sensitivity when touched in certain spots

When to Consult Your Veterinarian

Do not start, stop, or change your dog’s pain medication without your vet’s guidance. Grapiprant is a prescription drug, which means your vet needs to evaluate your dog, confirm an arthritis diagnosis, and monitor for any side effects over time.

If your dog is already on an NSAID or another pain medication, switching to grapiprant requires careful planning — some medications should not be combined, and there needs to be a washout period between them.

Honest Look at the Study’s Limits

This study did not include a placebo (control) group — a group of similar dogs given a dummy treatment to compare against. Without that comparison, it is harder to be completely certain that every improvement was due to the drug alone, rather than natural fluctuation in symptoms or the simple effect of owners paying closer attention.

That said, the off–on–off design helps address this limitation. Seeing changes that align with when the medication is given and withdrawn adds credibility. Future studies with placebo groups would strengthen the findings further. Researchers also noted that the blood metabolomics data could lead to new ways of predicting which dogs will benefit most — an avenue worth exploring.

The Bottom Line

Grapiprant helped 36 arthritic dogs move more easily over 60 days, and their blood chemistry shifted in ways consistent with reduced inflammation. This adds real-world support to what vets already know: grapiprant is a useful tool for managing dog arthritis pain.

If your dog is struggling with joint pain, do not wait for it to get worse. Talk to your vet about whether grapiprant or another pain management plan is the right fit. Arthritis is not curable, but with the right treatment, most dogs can enjoy a much more comfortable, active life.


This article summarizes peer-reviewed research for educational purposes. Always consult with your veterinarian for personalized advice about your pet’s health and behavior.

Reference

Grapiprant Improved Mobility in Dogs—and Changed Their Blood Metabolome (2026). Frontiers in Veterinary Science. DOI: https://doi.org/10.3389/fvets.2026.1811478